AddLife AB (publ)
Research AddLife AB (publ) (ALIF-B) on Bullrun: valuation model: 9.8% overvalued, market cap SEK 20.00B, P/E 33.6, dividend yield 0.9%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerALIF-B
- ExchangeST
- CountrySweden
- SectorHealthcare
- IndustryMedical Instruments & Supplies
- CurrencySEK
- Valuation signal9.8% overvalued
- Market capSEK 20.00B
- P/E33.6
- Dividend yield0.9%
- Financial periodQ2 2026
- RevenueSEK 2.72B
- Net incomeSEK 130.00M
- Free cash flowSEK 165.00M
- Gross margin39.5%
Valuation Snapshot
Bullrun's latest valuation model marks AddLife AB (publ) as 9.8% overvalued; latest market cap is SEK 20.00B; P/E is 33.6; dividend yield is 0.9%.
Peer valuation comparison
Latest P/E is 33.56x versus a Healthcare sector median of 24.46x (37.2% above).
Latest dividend yield is 0.89% versus a Healthcare sector median of 2.11% (57.8% below).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | SEK 10.44B | SEK 560.00M | n/a | 38.1% | n/a | SEK 813.00M | SEK 4.77B | SEK 5.44B |
| FY2024 | SEK 10.29B | SEK 254.00M | SEK 845.00M | 37.5% | 2.06 | SEK 331.00M | SEK 4.54B | SEK 5.31B |
| FY2023 | SEK 9.69B | SEK 192.00M | SEK 547.00M | 37.2% | 1.56 | SEK 272.00M | SEK 4.79B | SEK 4.96B |
| FY2022 | SEK 9.08B | SEK 483.00M | SEK 696.00M | 37.7% | 3.95 | SEK 376.00M | n/a | SEK 4.97B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-27 | SEK 20.00B | 33.6 | 0.9% | 1.5 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 1.5 SEK, yield 0.9%.
| Year | Dividends/share |
|---|---|
| FY2024 | 0.5 SEK |
| FY2022 | 2 SEK |
About AddLife AB (publ)
AddLife AB (publ), together with its subsidiaries, provides instruments and equipment, consumables, and reagents primarily to medical care, research, colleges, and universities, as well as the food and pharmaceutical industries. The company operates in two segments, Labtech and Medtech. The Labtech segment offers products, solutions, and services in the areas of diagnostics, and biomedical research and laboratory analysis.
Related stock research
Other Healthcare stocks
Frequently asked questions
Is AddLife AB (publ) overvalued or undervalued?
Bullrun's valuation model currently marks AddLife AB (publ) as 9.8% overvalued.
What is AddLife AB (publ)'s market cap?
AddLife AB (publ)'s market capitalization is SEK 20.00B.
What is AddLife AB (publ)'s P/E ratio?
AddLife AB (publ)'s price-to-earnings (P/E) ratio is 33.6.
Does AddLife AB (publ) pay a dividend?
AddLife AB (publ) has a dividend yield of 0.9%.
What does AddLife AB (publ) do?
AddLife AB (publ), together with its subsidiaries, provides instruments and equipment, consumables, and reagents primarily to medical care, research, colleges, and universities, as well as the food and pharmaceutical industries. The company operates in two segments, Labtech and Medtech. The Labtech segment offers products, solutions, and services in the areas of diagnostics, and biomedical research and laboratory analysis.